The Gale readResearch

Menopause Did Not Accelerate Gray Matter Loss in 843 Women

A Nature Communications study measured brain change across puberty, pregnancy and menopause in 1,095 women and girls using one set of methods; menopause was the transition where the volume loss did not show up, and the authors are careful about what that absence proves.

By Gale Staff · September 12, 2026 · Nature Communications

Clinician review pending — this analysis joins search indexes only after a licensed reviewer signs it.

The short answer

In the menopause arm of this study, crossing the transition was not accompanied by faster gray matter loss — the 120 women who went from premenopausal to postmenopausal between two MRI scans were the only group whose total gray matter did not measurably shrink. Total gray matter fell by 0.033 mm³ per month in women who stayed premenopausal and by 0.025 in women already past menopause, both statistically significant, while the transitioning group's 0.013 did not clear the corrected threshold (p = 0.017 against a cutoff of 0.0055). The three groups did not differ significantly from one another when tested directly, and the authors write that this null reflects the groups they could define from a single yes-or-no survey question rather than evidence that nothing changes across the transition.

The headline says shrinkage; the study says the opposite

A woman in her early fifties is in the kitchen at eleven at night with her phone, reading a headline about brain shrinkage and menopause. She has had a year of the word that will not arrive, the walk into a room that empties itself of its reason, the meeting where she loses the thread of her own sentence. She has been telling herself it is sleep, or work, or the thing everyone her age says about names. The headline reads like confirmation of the fear underneath all of that: that something is being taken away, and that it is not coming back.

The study under the headline runs the other direction. Published in Nature Communications on 8 September 2026 by Sophie van 't Hof, Marieke Bos, Milou Straathof, Eveline Crone and Elseline Hoekzema, it compared brain change across the three major hormonal transitions of female life — puberty, pregnancy and menopause — using the same measurements and the same analysis for each. Puberty and pregnancy both came with widespread cortical gray matter loss. Menopause was the one where the loss did not appear. The lagging question, the one still standing after the coverage moves on, is what a finding shaped like an absence can actually carry.

What the study did

The design is a comparison of three separate longitudinal cohorts, 1,095 women and girls in total, each scanned twice, each contributing a rate of brain change between the two scans rather than a single snapshot. The puberty cohort held 142 girls, the pregnancy cohort 110 women, and the menopause cohort 843 women drawn from UK Biobank, the British research resource that recruited half a million adults aged 40 to 69 and began inviting a subset back for brain imaging in 2014.

Within the menopause cohort, three groups were defined by how a woman answered one question at each visit — whether her periods had stopped. Forty-nine answered no both times and form the stable premenopausal group. One hundred and twenty answered no at the first scan and yes at the second: these are the women who crossed the transition while the study was watching. Six hundred and seventy-four answered yes both times, the stable postmenopausal group. Women who had undergone hysterectomy (17) or removal of both ovaries (19) were excluded, so this is spontaneous menopause only.

The measurement is volume of gray matter, adjusted for head size and expressed as a monthly rate of change, because the gap between scans varied from woman to woman. Two questions were then asked of it: whether each group's own rate differed from zero, and whether the groups differed from each other. The stable groups are the point of the design — without an age-matched comparison, any shrinkage during the menopausal years is indistinguishable from the shrinkage of ordinary aging.

What it found

In puberty the change is unmistakable. Girls scanned before and after their first period lost total gray matter at 0.13 mm³ per month (p < 0.001) and cortical volume at 0.16, while girls whose status did not change over the same window showed no significant loss at all. The pregnancy cohort showed the same broad picture of cortical reduction. Neither is treated as harm in this literature: the prevailing reading of adolescent and pregnancy-related gray matter loss is remodelling, a pruning that sharpens circuits rather than degrading them.

The menopause numbers are an order of magnitude smaller and point the other way. Women who stayed premenopausal lost total gray matter at 0.033 mm³ per month and women already past menopause at 0.025, both comfortably significant. The 120 women who actually crossed the transition lost 0.013 per month, and that figure did not survive the correction applied for multiple comparisons — p = 0.017 against a required threshold of 0.0055. Cortical volume repeated the pattern almost exactly: 0.033 and 0.028 in the stable groups, 0.013 and not significant in the transitioning one.

Two details complicate the clean version of this. Below the cortex, volume fell significantly in all three groups, the transitioning women included (p < 0.001), so the apparent pause is specific to cortical and total gray matter rather than to the whole brain. And a pattern analysis, which asks which regions change together rather than how much, did separate the transitioning women from the stable postmenopausal group (p = 0.030), with the strongest contributions from frontal regions. Something is distinguishable about the transition; it is just not volume loss. An analysis excluding every woman who reported hormone therapy at either visit left the results unchanged.

Why an absence of loss is not proof of protection

The most important limit is one the arithmetic makes easy to miss. When the three groups were tested directly against each other, they did not differ significantly (F(2,840) = 2.11, p = 0.122). The headline contrast is not group against group; it is each group against zero, and one group clearing that bar while another does not is not the same as those two groups differing from each other. A transitioning group of 120 also yields a less precise estimate than a stable group of 674, and a smaller group is easier to fail to find an effect in.

The staging is coarse. Menopausal status came from a single self-reported item, which the authors note does not meet the standard STRAW+10 criteria and cannot separate perimenopause from premenopause — meaning some women counted as stable premenopausal may already have been in the transition, blurring the contrast in the direction of the finding. Timing varied widely too: the transitioning group's second scan came on average 2.16 years after the reported final period, with a standard deviation of 2.14, and the stable postmenopausal group's first scan 5.85 years after, with a standard deviation of 4.42.

The authors state the boundary themselves, and it is worth quoting rather than paraphrasing: null findings in the menopausal cohort should be interpreted cautiously, as reflecting the available operationally defined groups rather than as evidence of an absence of brain change across the full menopausal transition. They also flag that the three cohorts were scanned on different machines and were deliberately not harmonised, so comparisons of absolute magnitude across transitions carry more uncertainty than comparisons within one.

Two menopause brain studies, two different questions

This finding sits alongside another that reached the news five weeks earlier and appears to contradict it. A cohort study in JAMA Network Open, published 3 August 2026, followed 2,603 older women for up to 18 years and found earlier menopause associated with faster cognitive decline and earlier Alzheimer diagnosis, with the one substantial effect being accumulation of white matter lesions among women with spontaneous menopause.

The two are answering different questions. The JAMA cohort asks what age at menopause marks for a woman's brain decades later; the Nature Communications cohort asks what happens to gray matter volume in the couple of years either side of the final period. A transition that leaves cortical volume roughly where it was is entirely compatible with the age that transition arrives carrying information about later risk. And neither study measured the symptom the woman in the kitchen actually came with: no cognitive testing appears in this menopause analysis at all. Structure is not symptoms, and this study speaks only to structure.

What this study can't tell you

  • Whether menopausal brain fog is permanent, or whether it happens at all. This analysis measured brain volume, not cognition; no memory or attention testing was included in the menopause cohort.
  • Whether the transitioning women genuinely differ from the others. The direct between-group comparison was not significant (p = 0.122), so the contrast rests on each group's rate against zero.
  • Whether perimenopause, the symptomatic window most women mean when they say menopause, is spared. A single yes-or-no question about periods stopping cannot stage it.
  • Whether any of this holds for surgical menopause. Women who had a hysterectomy or had both ovaries removed were excluded.
  • Whether hormone therapy changes the picture. Excluding women who used it left the findings intact, which is a check for distortion rather than a test of what the therapy does.
  • Whether the brain beneath the cortex follows the same pattern. Subcortical volume declined significantly in every group, transitioning women included.
  • What happens further out. Scans clustered within a few years of the reported final period, with wide variation, so a longer arc after menopause is not covered.

The Gale read

The useful thing in this paper is the reframe, not the reassurance. Measured the same way as puberty and pregnancy, menopause did not look like a remodelling event in cortical volume, which is genuinely interesting given how readily the transition gets described as the brain being rebuilt. But the sentence that will travel from it — that menopause does not shrink the brain — is stronger than the evidence underneath, because the study's own direct comparison between groups found nothing, the transitioning group was 120 women staged by one survey question, and volume below the cortex kept falling in everybody. What can be said is narrower and still worth having: in the best like-for-like comparison yet run, the years around the final period did not show accelerated cortical loss, and the alarming version of this story was never the one the data supported either. A woman noticing her memory in her fifties is not reading a scan, and this paper does not tell her what her own brain is doing.

Common questions

Does menopause shrink your brain?

Not detectably in this study. Among 120 women scanned before and after their final period, total gray matter change did not reach statistical significance (0.013 mm³ per month, p = 0.017 against a corrected threshold of 0.0055), while women who stayed premenopausal or were already postmenopausal both showed significant loss, at roughly 0.033 and 0.025. The groups were not significantly different from each other when compared directly, and volume below the cortex fell in all three.

Is menopause brain fog permanent?

This study cannot answer that, because it measured no cognition at all. It tracked brain volume on MRI scans in 843 women and never tested memory, attention or word-finding, so nothing in it describes what brain fog is, how long it lasts, or whether it resolves. The finding is about structure only.

Does menopause cause brain damage?

Nothing in this study describes damage. The transition group showed no measurable cortical volume loss, and where such loss does appear in this literature — adolescence and pregnancy, both far larger here — researchers read it as circuit remodelling rather than injury. A smaller volume in these datasets is not a wound.

Does menopause raise dementia risk?

This study did not measure dementia. A separate cohort study in JAMA Network Open, following 2,603 older women for up to 18 years, did associate earlier age at menopause with earlier Alzheimer diagnosis and faster cognitive decline, at effect sizes small enough that no individual woman would perceive them. That is a question about when menopause arrives, not about what the transition itself does to gray matter.

Sources

  1. 1.van 't Hof, S. R., Bos, M. G. N., Straathof, M., Crone, E. A., & Hoekzema, E. A. (2026). Puberty, pregnancy, and menopause show shared and distinct structural changes across the lifespan. Nature Communications, 17(1), 9360. link
  2. 2.Europe PMC record for van 't Hof et al. (2026), Puberty, pregnancy, and menopause show shared and distinct structural changes across the lifespan, Nature Communications 17(1), PMID 42711329. link
  3. 3.Campagna, M. P., Schneider, J. A., Barnes, L. L., Arfanakis, K., Levi Dunietz, G., Bennett, D. A., & Bove, R. M. (2026). Age at Menopause and Brain Atrophy Among Older Women. JAMA Network Open, 9(8). link

Read the study →

3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

More from Gale Staff

The Latest Health Research →

Published September 12, 2026 · Gale Staff

All Gale Staff analyses →